Advanced

Atrial fibrillation management: a prospective survey in ESC Member Countries - The Euro Heart Survey on Atrial Fibrillation

Nieuwlaat, R; Capucci, A; Camm, A J; Olsson, Bertil LU ; Andresen, D; Davies, D W; Cobbe, S; Breithardt, G; Le Heuzey, J Y and Prins, M H, et al. (2005) In European Heart Journal 26(22). p.2422-2434
Abstract
Aims To describe atrial fibrillation (AF) management in member countries of the European Society of Cardiology (ESC) and to verify cardiology practices against guidelines. Methods and results Among 182 hospitals in 35 countries, 5333 ambulant and hospitalized AF patients were enrolled, in 2003 and 2004. AF was primary or secondary diagnosis, and was confirmed on ECG in the preceding 12 months. Clinical type of AF was reported to be first detected in 978, paroxysmal in 1517, persistent in 1167, and permanent in 1547 patients. Concomitant diseases were present in 90% of all patients, causing risk factors for stroke to be also highly prevalent (86%). As many as 69% of patients were symptomatic at the time of the survey; among asymptomatic... (More)
Aims To describe atrial fibrillation (AF) management in member countries of the European Society of Cardiology (ESC) and to verify cardiology practices against guidelines. Methods and results Among 182 hospitals in 35 countries, 5333 ambulant and hospitalized AF patients were enrolled, in 2003 and 2004. AF was primary or secondary diagnosis, and was confirmed on ECG in the preceding 12 months. Clinical type of AF was reported to be first detected in 978, paroxysmal in 1517, persistent in 1167, and permanent in 1547 patients. Concomitant diseases were present in 90% of all patients, causing risk factors for stroke to be also highly prevalent (86%). As many as 69% of patients were symptomatic at the time of the survey; among asymptomatic patients, 54% were previously experienced symptoms. Oral anticoagulation was prescribed in 67 and 49% of eligible and ineligible patients, respectively. A rhythm control strategy was applied in 67% of currently symptomatic patients and in 44% of patients who never experienced symptoms. Conclusion This survey provides a unique snapshot of current AF management in ESC member countries. Discordance between guidelines and practice was found regarding several issues on stroke prevention and antiarrhythmic therapy. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
control, rate control, rhythm, anticoagulation, guidelines, atrial fibrillation, heart failure
in
European Heart Journal
volume
26
issue
22
pages
2422 - 2434
publisher
Oxford University Press
external identifiers
  • wos:000233044800016
  • pmid:16204266
  • scopus:27644529713
ISSN
1522-9645
DOI
10.1093/eurheartj/ehi505
language
English
LU publication?
yes
id
7aed8ddb-508f-4bc0-8a80-53814c5c3208 (old id 214271)
date added to LUP
2007-08-03 15:32:25
date last changed
2016-09-20 03:44:20
@article{7aed8ddb-508f-4bc0-8a80-53814c5c3208,
  abstract     = {Aims To describe atrial fibrillation (AF) management in member countries of the European Society of Cardiology (ESC) and to verify cardiology practices against guidelines. Methods and results Among 182 hospitals in 35 countries, 5333 ambulant and hospitalized AF patients were enrolled, in 2003 and 2004. AF was primary or secondary diagnosis, and was confirmed on ECG in the preceding 12 months. Clinical type of AF was reported to be first detected in 978, paroxysmal in 1517, persistent in 1167, and permanent in 1547 patients. Concomitant diseases were present in 90% of all patients, causing risk factors for stroke to be also highly prevalent (86%). As many as 69% of patients were symptomatic at the time of the survey; among asymptomatic patients, 54% were previously experienced symptoms. Oral anticoagulation was prescribed in 67 and 49% of eligible and ineligible patients, respectively. A rhythm control strategy was applied in 67% of currently symptomatic patients and in 44% of patients who never experienced symptoms. Conclusion This survey provides a unique snapshot of current AF management in ESC member countries. Discordance between guidelines and practice was found regarding several issues on stroke prevention and antiarrhythmic therapy.},
  author       = {Nieuwlaat, R and Capucci, A and Camm, A J and Olsson, Bertil and Andresen, D and Davies, D W and Cobbe, S and Breithardt, G and Le Heuzey, J Y and Prins, M H and Levy, S and Crijns, H J G M},
  issn         = {1522-9645},
  keyword      = {control,rate control,rhythm,anticoagulation,guidelines,atrial fibrillation,heart failure},
  language     = {eng},
  number       = {22},
  pages        = {2422--2434},
  publisher    = {Oxford University Press},
  series       = {European Heart Journal},
  title        = {Atrial fibrillation management: a prospective survey in ESC Member Countries - The Euro Heart Survey on Atrial Fibrillation},
  url          = {http://dx.doi.org/10.1093/eurheartj/ehi505},
  volume       = {26},
  year         = {2005},
}